SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: macker who wrote (1384)6/19/1998 10:36:00 AM
From: Andrew H  Read Replies (2) | Respond to of 5402
 
Its certainly possible given the potential size of the reward even though the odds are against, repeat against, ultimate success.

But IF there is a buyout, ultimate product success is not really an issue for shareholders...



To: macker who wrote (1384)6/19/1998 10:37:00 AM
From: Jim B  Read Replies (1) | Respond to of 5402
 
yes, and if these institutions do buy in... with the float
having been dried up.. or soon to be... they will only be
able to get their orders filled if the MMs bring the BID
side up several times over to entice us to sell our shares..

and most the people I've talked to wont' let their shares
go until we at least hit $4 or so.... of course, we all know
that could change.. people could lower or raise their target
prices as they see fit based on market changes or personal
needs/interest...

but based on what SGNC claims to have hold of and with BATTELLE'S support... and with the potential $20BILLION market to be tapped into.. and that we're talking about a life saving product that
has been worked on for 30years... and most of us haven't even been invested 30days... well, it would seem like we're at the right
place at the right time with the right people and the right
product. I think it's safe to say that nearly anything is
possible with this one... you can't normally say that with
a BB stock.. the more we learn about SGNC.. the more I think.. although there is still more work to do... that this could
certainly be one of the biggest success stories in a very long
time... no hype.. just basing that on what we know thus far.

take care

jim




To: macker who wrote (1384)6/19/1998 11:08:00 AM
From: drdan  Read Replies (1) | Respond to of 5402
 
Exactly right, Macker.....Andrew, you have no idea how many hundreds of MILLIONs of dollar large pharma firms spend on R&D that goes absolutely nowhere.....Baxter, for example, just blew $110 MILLION on a factory they may NEVER USE.....this product has a much better risk-reward ratio than many products out there and in the past....and large brokerage firms will dive in once a large pharma company "gives its blessing" by funding product research there are numerous examples of this in the recent past....